Literature DB >> 31145719

Babesiosis Surveillance - United States, 2011-2015.

Elizabeth B Gray1, Barbara L Herwaldt1.   

Abstract

PROBLEM/CONDITION: Babesiosis is caused by parasites of the genus Babesia, which are transmitted in nature by the bite of an infected tick. Babesiosis can be life threatening, particularly for persons who are asplenic, immunocompromised, or elderly. PERIOD COVERED: 2011-2015. DESCRIPTION OF SYSTEM: CDC has conducted surveillance for babesiosis in the United States since January 2011, when babesiosis became a nationally notifiable condition. Health departments in states in which babesiosis is reportable voluntarily notify CDC of cases through the National Notifiable Diseases Surveillance System (NNDSS) and submit supplemental case information by using a babesiosis-specific case report form (CRF). As of 2015, babesiosis was a reportable condition in 33 states compared with 22 states in 2011.
RESULTS: For the 2011-2015 surveillance period, CDC was notified of 7,612 cases of babesiosis (6,277 confirmed [82.5%] and 1,335 probable [17.5%]). Case counts varied from year to year (1,126 cases for 2011, 909 for 2012, 1,761 for 2013, 1,742 for 2014, and 2,074 for 2015). Cases were reported among residents of 27 states. However, 7,194 cases (94.5%) occurred among residents of seven states with well-documented foci of tickborne transmission (i.e., Connecticut, Massachusetts, Minnesota, New Jersey, New York, Rhode Island, and Wisconsin). Maine (152 cases) and New Hampshire (149 cases) were the only other states that reported >100 cases for the 5-year period, and both states also reported increasing numbers of cases over time. The median age of the 7,173 patients with available information was 63 years (range: <1-99 years; interquartile range: 51-73 years); 4,156 (57.9%) were aged ≥60 years, and 15 (<1%) were aged <1 year. The proportion of patients with symptom onset during June-August was >70% for each of the 5 surveillance years. Approximately half (3,004 of 6,404 [46.9%]) of the patients with available data were hospitalized at least overnight. Hospitalization rates ranged from 16.0% among patients aged 10-19 years (16 of 100) to 72.6% among those aged ≥80 years (552 of 760). Hospitalizations were reported significantly more often among patients who were asplenic than among patients who were not (106 of 126 [84.1%] versus 643 of 1,396 [46.1%]). Fifty-one cases of babesiosis among recipients of blood transfusions were classified by the reporting health department as transfusion associated. The median intervals from the earliest date associated with each case of babesiosis to the initial report via NNDSS and submission of supplemental CRF data to CDC were approximately 3 months and 1 year, respectively.
INTERPRETATION: For the first 5 years of babesiosis surveillance, the reported cases occurred most frequently during June-August in the Northeast and upper Midwest. Maine and New Hampshire reported increasing numbers of cases over time, which suggests that foci of transmission might be expanding. Hospitalizations were common, particularly among patients who were asplenic or elderly. PUBLIC HEALTH ACTION: Persons who live in or travel to regions where babesiosis is endemic should avoid tick-infested areas, apply repellent to skin and clothing, conduct full-body inspections for ticks after being outdoors, and remove attached ticks with fine-tipped tweezers as soon as possible. Prevention measures are especially important for persons at risk for severe babesiosis. Increases in the number and geographic range of reported cases warrant investigation to identify contributory factors (e.g., changes in tick density or in testing or surveillance methods). Complete and timely submission of risk factor data could facilitate assessments of the geographic ranges and transmission routes of Babesia parasites. Efforts to allow for electronic submission of CRF data are under way at CDC; electronic submission is expected to improve the timeliness, uniformity, and completeness of the data.

Entities:  

Year:  2019        PMID: 31145719     DOI: 10.15585/mmwr.ss6806a1

Source DB:  PubMed          Journal:  MMWR Surveill Summ        ISSN: 1545-8636


  32 in total

1.  Evaluating the effectiveness of an integrated tick management approach on multiple pathogen infection in Ixodes scapularis questing nymphs and larvae parasitizing white-footed mice.

Authors:  Eliza A H Little; Scott C Williams; Kirby C Stafford; Megan A Linske; Goudarz Molaei
Journal:  Exp Appl Acarol       Date:  2019-12-18       Impact factor: 2.132

2.  Preventing infections in children and adults with asplenia.

Authors:  Grace M Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 3.  Lessons Learned for Pathogenesis, Immunology, and Disease of Erythrocytic Parasites: Plasmodium and Babesia.

Authors:  Vitomir Djokic; Sandra C Rocha; Nikhat Parveen
Journal:  Front Cell Infect Microbiol       Date:  2021-08-03       Impact factor: 6.073

4.  Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada.

Authors:  Ziyad O Allehebi; Farhan M Khan; Mark Robbins; Elizabeth Simms; Richard Xiang; Allam Shawwa; L Robbin Lindsay; Antonia Dibernardo; Clarice d'Entremont; Alex Crowell; Jason J LeBlanc; David J Haldane
Journal:  Emerg Infect Dis       Date:  2022-06       Impact factor: 16.126

5.  Babesiosis Occurrence Among United States Medicare Beneficiaries, Ages 65 and Older, During 2006-2017: Overall and by State and County of Residence.

Authors:  Mikhail Menis; Barbee I Whitaker; Michael Wernecke; Yixin Jiao; Anne Eder; Sanjai Kumar; Wenjie Xu; Jiemin Liao; Yuqin Wei; Thomas E MaCurdy; Jeffrey A Kelman; Steven A Anderson; Richard A Forshee
Journal:  Open Forum Infect Dis       Date:  2020-12-15       Impact factor: 3.835

Review 6.  Autoimmune Hemolytic Anemia Associated With Human Babesiosis.

Authors:  Pramuditha Rajapakse; Kamila Bakirhan
Journal:  J Hematol       Date:  2021-04-27

7.  Activity Comparison of Epigenetic Modulators against the Hemoprotozoan Parasites Babesia divergens and Plasmodium falciparum.

Authors:  Leen N Vanheer; Björn F C Kafsack
Journal:  ACS Infect Dis       Date:  2021-02-18       Impact factor: 5.578

8.  Rise in Babesiosis Cases, Pennsylvania, USA, 2005-2018.

Authors:  David Ingram; Tonya Crook
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

9.  Vertical Transmission: A Vector-Independent Transmission Pathway of Babesia microti in the Natural Reservoir Host Peromyscus leucopus.

Authors:  Danielle M Tufts; Maria A Diuk-Wasser
Journal:  J Infect Dis       Date:  2021-05-28       Impact factor: 5.226

10.  Parasite burden and red blood cell exchange transfusion for babesiosis.

Authors:  Jane O'Bryan; Amit Gokhale; Jeanne E Hendrickson; Peter J Krause
Journal:  J Clin Apher       Date:  2020-11-12       Impact factor: 2.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.